ConductScience.org, home

Paper9765387

Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer.

Angulo A and 3 others. J Virol, 1998. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. Papers, record 9765387. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9765387

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer.
PubMed
Journal
J Virol
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2020-07-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Angulo AA
2Messerle MM
3Koszinowski UHU H
4Ghazal PP

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytomegalovirusMajor topic
Enhancer Elements, GeneticMajor topic
MuromegalovirusMajor topic
3T3 Cells
Animals
Base Sequence
Cells, Cultured
Chimera
DNA, Viral
Genetic Complementation Test
Genome, Viral
Humans
Mice
Mutation
Open Reading Frames
Species Specificity
Transfection
Virulence

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-30627NIAID NIH HHSUnited StatesR01AI030627PubMed and NIHNIH RePORTER
CA-66167NCI NIH HHSUnited StatesR01CA066167PubMed and NIHNIH RePORTER
R29AI030627NIHNIH RePORTER

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11845833Sequence requirements for activation of replication by the SV40 transcriptional promoter or enhancer elements.Virology1991https://conductscience.org/library/papers/1845833PubMed
22660262Construction of large DNA segments in Escherichia coli.Science1989https://conductscience.org/library/papers/2660262PubMed
31317005Specific transcription factors stimulate simian virus 40 and polyomavirus origins of DNA replication.Mol Cell Biol1992https://conductscience.org/library/papers/1317005PubMed
41323848Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1323848PubMed
51324192Stimulation of SV40 DNA replication by the human c-myc enhancer.FEBS Lett1992https://conductscience.org/library/papers/1324192PubMed
67983714Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.J Virol1995https://conductscience.org/library/papers/7983714PubMed
77884867Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.J Virol1995https://conductscience.org/library/papers/7884867PubMed
87747475Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice.Virology1995https://conductscience.org/library/papers/7747475PubMed
97762288Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776.Virus Res1995https://conductscience.org/library/papers/7762288PubMed
108627801The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.J Virol1996https://conductscience.org/library/papers/8627801PubMed
118627802Developmental analysis of the cytomegalovirus enhancer in transgenic animals.J Virol1996https://conductscience.org/library/papers/8627802PubMed
128806515Rat cytomegalovirus has a unique immediate early gene enhancer.Virology1996https://conductscience.org/library/papers/8806515PubMed
138813719Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids.Mol Endocrinol1996https://conductscience.org/library/papers/8813719PubMed
148876134A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8876134PubMed
158970984
Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
J Virol1996https://conductscience.org/library/papers/8970984PubMed
168971012Analysis of the complete DNA sequence of murine cytomegalovirus.J Virol1996https://conductscience.org/library/papers/8971012PubMed
178995648Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells.J Virol1997https://conductscience.org/library/papers/8995648PubMed
189188579Transcriptional targeting of herpes simplex virus for cell-specific replication.J Virol1997https://conductscience.org/library/papers/9188579PubMed
199209066Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome.J Bacteriol1997https://conductscience.org/library/papers/9209066PubMed
209368051Transcriptional repression by zinc finger peptides. Exploring the potential for applications in gene therapy.J Biol Chem1997https://conductscience.org/library/papers/9368051PubMed

See all 40 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
27170759Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes.J Virol2016https://conductscience.org/library/papers/27170759PubMed
25856589A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection.PLoS Pathog2015https://conductscience.org/library/papers/25856589PubMed
25501994Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defenses.Virol Sin2014https://conductscience.org/library/papers/25501994PubMed
24516378Viral enhancer mimicry of host innate-immune promoters.PLoS Pathog2014https://conductscience.org/library/papers/24516378PubMed
22991040Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection.Med Microbiol Immunol2012https://conductscience.org/library/papers/22991040PubMed
21775459
Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.
J Virol2011https://conductscience.org/library/papers/21775459PubMed
21471238Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes.J Virol2011https://conductscience.org/library/papers/21471238PubMed
21106746
The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection.
J Virol2011https://conductscience.org/library/papers/21106746PubMed
20375164Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth.J Virol2010https://conductscience.org/library/papers/20375164PubMed
18684819In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation.J Virol2008https://conductscience.org/library/papers/18684819PubMed
17494084Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription.J Virol2007https://conductscience.org/library/papers/17494084PubMed
16973595Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.J Virol2006https://conductscience.org/library/papers/16973595PubMed
15890957Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture.J Virol2005https://conductscience.org/library/papers/15890957PubMed
15596821Mouse cytomegalovirus early M112/113 proteins control the repressive effect of IE3 on the major immediate-early promoter.J Virol2005https://conductscience.org/library/papers/15596821PubMed
15542631Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication.J Virol2004https://conductscience.org/library/papers/15542631PubMed
14694106Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro.J Virol2004https://conductscience.org/library/papers/14694106PubMed
12692210Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.J Virol2003https://conductscience.org/library/papers/12692210PubMed
12610136The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection.J Virol2003https://conductscience.org/library/papers/12610136PubMed
12584345An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis.J Virol2003https://conductscience.org/library/papers/12584345PubMed
11739696Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication.J Virol2002https://conductscience.org/library/papers/11739696PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9765387

GET https://conductscience.org/api/papers/v1/9765387/references?page=2